ALDER BIOPHARMACEUTICALS INC's ticker is ALDR and the CUSIP is 014339105. A total of 146 filers reported holding ALDER BIOPHARMACEUTICALS INC in Q4 2016. The put-call ratio across all filers is 0.22 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $25,965,000 | -29.3% | 1,248,310 | +11.3% | 0.00% | -33.3% |
| Q3 2016 | $36,738,000 | +38.6% | 1,121,086 | +5.6% | 0.01% | +50.0% |
| Q2 2016 | $26,516,000 | +80.0% | 1,061,912 | +76.5% | 0.00% | +100.0% |
| Q1 2016 | $14,733,000 | -25.6% | 601,590 | +0.3% | 0.00% | -33.3% |
| Q4 2015 | $19,812,000 | +2.7% | 599,808 | +1.9% | 0.00% | 0.0% |
| Q3 2015 | $19,289,000 | +12.0% | 588,809 | +81.1% | 0.00% | 0.0% |
| Q2 2015 | $17,219,000 | +187.1% | 325,067 | +56.4% | 0.00% | +200.0% |
| Q1 2015 | $5,998,000 | +48.8% | 207,825 | +50.0% | 0.00% | 0.0% |
| Q4 2014 | $4,031,000 | +128.4% | 138,561 | -0.4% | 0.00% | – |
| Q3 2014 | $1,765,000 | -43.1% | 139,168 | -9.9% | 0.00% | -100.0% |
| Q2 2014 | $3,100,000 | – | 154,449 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management III, LLC | 2,942,203 | $36,042,000 | 9.93% |
| Foresite Capital Management II, LLC | 1,043,832 | $12,787,000 | 5.18% |
| Redmile Group, LLC | 6,476,766 | $79,340,000 | 3.91% |
| DAFNA Capital Management LLC | 346,013 | $4,239,000 | 2.63% |
| Cormorant Asset Management, LP | 900,000 | $11,025,000 | 1.95% |
| SENZAR ASSET MANAGEMENT, LLC | 641,170 | $7,854,000 | 1.92% |
| Asymmetry Capital Management, L.P. | 105,228 | $1,289,000 | 1.50% |
| New Leaf Venture Partners, L.L.C. | 171,364 | $2,099,000 | 0.97% |
| EMERALD ADVISERS, LLC | 1,578,477 | $19,336,000 | 0.79% |
| BB BIOTECH AG | 2,266,008 | $27,759,000 | 0.77% |